Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnson & Johnson

http://www.jnj.com

Latest From Johnson & Johnson

Optum Rx Reveals Humira Biosimilar Plan To ‘Support Advancement Of The Market’

United Health's pharmacy benefit manager outlined plans for early inclusion of up to three biosimilar versions of adalimumab on its formularies in 2023, at parity to the brand.

Biosimilars Market Access

AC Immune and J&J Advance Tau-Targeting Alzheimer’s Vaccine

AC Immune has seen two big disappointments in its Alzheimer’s pipeline this year, but its partner Johnson & Johnson has put its faith in a novel vaccine-like approach to targeting the disease.

Neurology Commercial

The Busiest Dealmakers Of 2022

With only weeks to go in 2022, the three major pharmas each had inked between 16 and 20 deals. Meanwhile, Pfizer has been less busy with 12 deals, but those include M&A totaling $18.2bn.

Outlook 2023 M & A

US FDA Says Confirmatory Trials Should Start Before Accelerated Approval But Is Not ‘Dogmatic’

Beginning confirmatory trials before the accelerated approval is granted shortens the time between clearance and the confirmation of benefit, when patients are at risk, said Oncology Center of Excellence Director Richard Pazdur.

Clinical Trials Review Pathway
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Acclarent Inc.
    • Actelion Pharmaceuticals Ltd.
    • AdvanceCOR GmbH
    • ALZA Corporation
    • Alios BioPharma, Inc.
    • Animas Corporation
    • Aragon Pharmaceuticals, Inc.
    • Auris Health, Inc.
    • Auris Surgical Robotics
    • BeneVir Biopharm, Inc.
    • BioMedical Enterprises, Inc.
    • Biosense Webster, Inc.
    • Calibra Medical, Inc.
    • Centyrex Internal Venture
    • Cilag AG
    • Cerenovus
    • Codman & Shurtleff, Inc
    • Coherex Medical, Inc.
    • Conor Medsystems, Inc.
    • Cordis Webster, Inc.
    • CorImmun GmbH
    • Cougar Biotechnology, Inc.
    • Covagen AG
    • Crucell N.V.
    • DePuy Mitek, Inc.
    • DePuy Orthopaedics, Inc.
    • DePuy Synthes, Inc.
    • Ensure Medical
    • Ethicon, Inc.
    • FemRx Inc.
    • Flexible Stenting Solutions, Inc.
    • Gynecare, Inc.
    • Hansen Medical, Inc.
    • Innovative Surgical Solutions, LLC
    • Interventional Spine, Inc.
    • Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
    • Janssen Diagnostics
    • Janssen Pharmaceuticals
    • Janssen Vaccines & Prevention B.V.
    • JointPoint, Inc.
    • LifeScan, Inc.
    • Medical Enterprises Distribution, LLC
    • Medos International SARL
    • Megadyne Medical Products, Inc.
    • Mentor Corporation
    • Micrus Endovascular Corporation
    • Molsaic Internal Venture
    • Momenta Pharmaceuticals, Inc.
    • NeoStrata Company, Inc.
    • Neuravi Limited
    • NeuWave Medical, Inc.
    • Novira Therapeutics
    • Omrix Biopharmaceuticals, Inc.
    • Ortho Biotech Products, L.P.
    • Ortho-McNeil, Inc.
    • Orthotaxy
    • Peninsula Pharmaceuticals, Inc.
    • Pulsar Vascular Inc
    • RespiVert Ltd.
    • Scios, Inc.
    • Selected Nerve Stimulation Internal Ventures
    • Sentio, LLC
    • Sequus Pharmaceuticals
    • Stem Cell Internal Venture
    • Synthes, Inc.
    • Tibotec
    • Torax Medical, Inc.
    • Triage Medical, Inc.
    • Verb Surgical Inc.
    • Veridex
    • Vigor Sub, Inc.
    • Vistakon
    • XO1 Limited
    • TARIS Biomedical LLC
    • Verb Surgical, Inc.
UsernamePublicRestriction

Register